Gene-SNP | Genotype | Cases (%) | Controls (%) | OR | 95%CI | p value |
---|---|---|---|---|---|---|
All subjects* | Â | (n = 358) | (n = 629) | Â | Â | Â |
   CYP2E1-rs2031920 | CC | 228 (64.0) | 412 (66.0) | 1.0 |  |  |
 | CT | 108 (30.3) | 186 (29.8) | 1.06 | 0.78-1.42 | 0.72 |
 | TT | 20 (5.6) | 26 (4.2) | 1.21 | 0.63-2.34 | 0.57 |
   CYP2E1-rs6413432 | TT | 188 (56.0) | 360 (59.6) | 1.0 |  |  |
 | AT | 121 (36.0) | 202 (33.4) | 1.10 | 0.82-1.49 | 0.52 |
 | AA | 27 (8.0) | 42 (7.0) | 1.07 | 0.61-1.85 | 0.82 |
   GSTP1-rs947894 | AA | 181 (65.1) | 346 (66.3) | 1.0 |  |  |
 | AG | 84 (30.2) | 159 (30.5) | 0.98 | 0.70-1.37 | 0.91 |
 | GG | 13 (4.7) | 17 (3.3) | 1.41 | 0.65-3.03 | 0.39 |
   MPO-rs2333227 | GG | 223 (69.0) | 381 (69.3) | 1.0 |  |  |
 | GA | 93 (28.8) | 157 (28.6) | 0.95 | 0.69-1.30 | 0.74 |
 | AA | 7 (2.2) | 12 (2.2) | 1.15 | 0.43-3.07 | 0.78 |
   NQO1-rs1800566 | CC | 96 (27.7) | 169 (27.3) | 1.0 |  |  |
 | CT | 159 (45.8) | 320 (51.6) | 0.87 | 0.63-1.21 | 0.41 |
 | TT | 92 (26.5) | 131 (21.1) | 1.18 | 0.81-1.72 | 0.39 |
EBV/IgA/VCA+** | Â | (n = 341) | (n = 280) | Â | Â | Â |
   CYP2E1-rs2031920 | CC | 214 (63.1) | 186 (66.9) | 1.0 |  |  |
 | CT | 105 (31.0) | 82 (29.5) | 1.10 | 0.77-1.58 | 0.59 |
 | TT | 20 (5.9) | 10 (3.6) | 1.39 | 0.61-3.15 | 0.43 |
   CYP2E1-rs6413432 | TT | 175 (54.7) | 160 (58.8) | 1.0 |  |  |
 | AT | 118 (36.9) | 93 (34.2) | 1.12 | 0.79-1.60 | 0.52 |
 | AA | 27 (8.4) | 19 (7.0) | 1.03 | 0.54-1.98 | 0.92 |
   GSTP1-rs947894 | AA | 172 (65.4) | 168 (69.7) | 1.0 |  |  |
 | AG | 79 (30.0) | 67 (27.8) | 1.09 | 0.73-1.63 | 0.66 |
 | GG | 12 (4.6) | 6 (2.5) | 1.80 | 0.65-5.01 | 0.26 |
   MPO-rs2333227 | GG | 217 (70.2) | 159 (66.5) | 1.0 |  |  |
 | GA | 85 (27.5) | 72 (30.1) | 0.84 | 0.57-1.23 | 0.37 |
 | AA | 7 (2.3) | 8 (3.4) | 0.77 | 0.27-2.22 | 0.63 |
   NQO1-rs1800566 | CC | 91 (27.6) | 73 (26.6) | 1.0 |  |  |
 | CT | 151 (45.8) | 139 (50.6) | 0.88 | 0.60-1.31 | 0.53 |
 | TT | 88 (26.7) | 63 (22.9) | 1.11 | 0.70-1.74 | 0.66 |